1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Arrowhead Pharmaceuticals Inc (ARWR) CEO Christopher Richard Anzalone Sold $5.8 million of Shares

October 23, 2020 | About:

CEO of Arrowhead Pharmaceuticals Inc (30-Year Financial, Insider Trades) Christopher Richard Anzalone (insider trades) sold 100,000 shares of ARWR on 10/23/2020 at an average price of $58.21 a share. The total sale was $5.8 million.

Arrowhead Pharmaceuticals Inc is a biotechnology company. It is engaged in the development of medicine to treat diseases such as hepatitis B, and thrombosis with a genetic origin, primarily divided by the overproduction of one or more proteins. Arrowhead Pharmaceuticals Inc has a market cap of $6.02 billion; its shares were traded at around $58.88 with and P/S ratio of 47.77. GuruFocus has detected 2 severe warning signs with Arrowhead Pharmaceuticals Inc. .

CEO Recent Trades:

  • CEO Christopher Richard Anzalone sold 100,000 shares of ARWR stock on 10/23/2020 at the average price of $58.21. The price of the stock has increased by 1.15% since.

CFO Recent Trades:

  • CFO Kenneth Allen Myszkowski sold 29,166 shares of ARWR stock on 10/20/2020 at the average price of $54.04. The price of the stock has increased by 8.96% since.

Directors and Officers Recent Trades:

  • Director Mauro Ferrari sold 10,000 shares of ARWR stock on 10/09/2020 at the average price of $48. The price of the stock has increased by 22.67% since.

For the complete insider trading history of ARWR, click here


Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)